EHS
EHS

Galcanezumab Safe, Effective for Reducing Monthly Migraine Headache Days



In patients with chronic migraine, monthly subcutaneous injections of galcanezumab at 120- and 240-mg doses were more effective than placebo for lowering the number of monthly migraine headache days.

Source link

EHS
Back to top button